VRTX · News · 20260824N
Crinetics Acquisition Financing
VERTEX PHARMACEUTICALS INC / MA · 2026-08-24 · Importance 58 · Surprise 42 · In source text
Third-party reporting says Vertex is progressing with its approximately $10 billion acquisition of Crinetics Pharmaceuticals. The report references the transaction in connection with Crinetics’ second-quarter 2026 results and notes recent analyst downgrades. No additional financing structure, closing date, or regulatory jurisdiction was provided.
Key facts
- Crinetics is progressing with its $10 billion acquisition by Vertex Pharmaceuticals. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| assets | positive | probable | +18.2% | Crinetics is progressing with its $10 billion acquisition by Vertex Pharmaceuticals. |